Skip to main content
Fig. 5 | BMC Nephrology

Fig. 5

From: Bioactive adrenomedullin and interleukin-6 in COVID-19: potential biomarkers of acute kidney injury and critical illness

Fig. 5

Receiver operating characteristic analysis of bio-ADM and IL-6 regarding the composite endpoint. Predictive values of bio-ADM (blue) and IL-6 (red) regarding the composite endpoint in COVID-19 patients. Area under the curve (AUC) bio-ADM: 0.83 (cut-off value of 38.7 pg/ml: sensitivity: 84.6%, specificity: 67.7%, p < 0.001). AUC IL-6: 0.89 (cut-off value 57.8 pg/ml: sensitivity: 84.6%, specificity: 78.7%, p < 0.001)

Back to article page

BMC Nephrology

ISSN: 1471-2369

Contact us